Aptevo Therapeutics Inc. (APVO): Price and Financial Metrics

Aptevo Therapeutics Inc. (APVO): $4.69

0.63 (+15.52%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add APVO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#116 of 383

in industry

APVO Price/Volume Stats

Current price $4.69 52-week high $92.62
Prev. close $4.06 52-week low $3.81
Day low $3.95 Volume 304,500
Day high $5.00 Avg. volume 102,554
50-day MA $6.07 Dividend yield N/A
200-day MA $19.20 Market Cap 2.01M

APVO Stock Price Chart Interactive Chart >


Aptevo Therapeutics Inc. (APVO) Company Bio


Aptevo Therapeutics, a biotechnology company, provides oncology and hematology therapeutics. Its marketed products include WinRho SDF for the treatment of autoimmune platelet disorders, as well as for the treatment of hemolytic disease of the newborn; and HepaGam B used for the prevention of hepatitis-B recurrence following liver transplantation in HBsAg-positive liver transplant patients, and for the treatment following exposure to hepatitis-B. The company was spun off from Emergent BioSolutions Inc. in 2016 and is based in Seattle, Washington.


APVO Latest News Stream


Event/Time News Detail
Loading, please wait...

APVO Latest Social Stream


Loading social stream, please wait...

View Full APVO Social Stream

Latest APVO News From Around the Web

Below are the latest news stories about APTEVO THERAPEUTICS INC that investors may wish to consider to help them evaluate APVO as an investment opportunity.

Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update

The Company's ALG.APV-527 Phase 1 Trial for the Treatment of Multiple Solid Tumors Continues to ProgressPlanning for APVO436 Phase 2 Trial Initiation in Both Relapsed/Refractory and Frontline AML OngoingExtended Cash Runway with $7 Million in Funding ...

Yahoo | November 14, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're closing out the trading week with a breakdown of the biggest pre-market stock movers worth watching for Friday morning!

William White on InvestorPlace | November 10, 2023

Aptevo to Present at Bio-Europe Conference

SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, ...

Yahoo | November 1, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!

William White on InvestorPlace | August 15, 2023

Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended June 30, 2023 and provided a business update, including duration of remission (DOR) data for its lead clinical candidate, APVO436.

Yahoo | August 10, 2023

Read More 'APVO' Stories Here

APVO Price Returns

1-mo -31.54%
3-mo -41.11%
6-mo -67.70%
1-year -94.77%
3-year -99.62%
5-year -99.15%
YTD -41.11%
2023 -92.20%
2022 -70.52%
2021 -78.53%
2020 299.98%
2019 -48.46%

Continue Researching APVO

Here are a few links from around the web to help you further your research on Aptevo Therapeutics Inc's stock as an investment opportunity:

Aptevo Therapeutics Inc (APVO) Stock Price | Nasdaq
Aptevo Therapeutics Inc (APVO) Stock Quote, History and News - Yahoo Finance
Aptevo Therapeutics Inc (APVO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!